The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for osilodrostat (Recordati Rare Diseases Australia Pty Ltd)
Active ingredients
osilodrostat
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
For the treatment of endogenous Cushing's syndrome in adults
Therapeutic area
Endocrinology